Pharmaceutical Executive, Jul 1, 2013 - Pharmaceutical Executive

ADVERTISEMENT

Pharmaceutical Executive, Jul 1, 2013
Features
Dangerous Liaisons: Terrorism and Pharma
By Miriam Halperin Wernli , Boaz Ganor
How vulnerable is Big Pharma to the predations of organized terrorist groups or that rogue malcontent with an agenda to wreak havoc on society?
Pharm Exec's 2013 Emerging Pharma Leaders
Meet the Emerging Pharma Leaders of 2013. These 15 trend setters represent the future of an industry that knows it must change: the question is how, and to what?
Country Report
Country Report: Colombia
Under the administration of President Juan Manuel Santos, Colombia is focusing on bolstering the commercial sector. Thanks to the ratification of free trade agreements with 14 countries around the world since 2011, including the United States, foreign direct investment reached a record high of COP 29 trillion (USD 16 billion) in 2012. While this is good news for the pharmaceutical industry, there is still a strong debate about how healthcare in Colombia can be improved.
Column
What is a Journal Reprint Worth?
By Ben Comer
Pharma and physicians worry about getting sunburned by the Sunshine Act.
Innovation Calls Across the C-suite: Lessons From Wall Street
By Richie Etwaru
The lifeblood of the life sciences industry is continuous innovation—it is not a business that can survive by standing still.
Seeking Supply Chain Security
By Jill Wechsler
FDA wants pharma leaders to do more to ensure drug quality at home and abroad. Our Washington correspondent Jill Wechsler reports.
From the Editor
Talent, Terror, and the Turnaround
By William Looney
Our lead feature this month on 15 new Emerging Pharma Leaders is a window into what makes our publication unique. In 2007, Pharm Exec began a systematic annual search to identify and highlight those men—and women—that in our purely editorial view had real prospects for a future key to the "c suite." Two of our early choices—Sanofi's Chris Viehbacher and Heather Bresch of Mylan—have made it to the very top, as CEO.

ADVERTISEMENT

Click here